Clinical TrialsSearch results
Number of results: 301
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2007-09-01
Other
- A phase I/II study of transjugular-transhepatic peritoneo-venous shunting for malignant ascites (JIVROSG-0201)
- Cancer-related refractory ascites
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-05
Other
- A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
- non-small cell lung cancer
- Nagoya City University thoracic oncology study group
- 2008-11-18
Other
- A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer
- Thymic cancer
- West Japan Oncology Group
- 2008-09-08
Other
- A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- West Japan Oncology Group
- 2008-09-12
Other
- A Phase II study of Gefitinib as First-Line Treatment for Elderly Patients with Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.
- Non-Small-Cell Lung Cancer
- Central Japan Lung Study Group
- 2009-04-08
Other
- A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)
- Malignant gastrointestinal obstruction
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase II study of systemic chemotherapy with TS-1 and CDDP followed by surgery in advanced gastric cancer with extensive lymph node metastasis(JCOG0405)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A phase II study of the Cladribine and Rituximab combination therapy for relapsed and refractory indolent B-cell Non-Hodgkin's Lymphoma.
- low grade B cell lymphoma
- refractory lymphoma treatment study group
- 2008-12-18
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26